Althea UK Launches Medicinal Cannabis Prescriber Platform and Commences First Assessments


  • Althea Concierge UK launched successfully with doctors already commencing their first assessments of patients for Althea medical cannabis products
  • Althea Concierge UK streamlines the prescription process and facilitates patient referrals from primary care doctors to Althea UK specialist prescribers
  • Althea and Drug Science joint educational meetings to be held in June are oversubscribed, with nearly 300 healthcare professionals registered to attend
  • Althea sponsored and participated in the recent IOTOD conference in Germany

United Kingdom, 31 May 2019: Australian medicinal cannabis company Althea Group Holdings Limited (ASX: AGH) through its wholly-owned subsidiary Althea MMJ UK Ltd (‘Althea’ or ‘the Company’), is pleased to announce the launch of Althea Concierge UK and the progression of its partnerships with Drug Science and the Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) scientific committees.

Please open the attachment provided to

/Public Release.